Translating transitions - How to decipher peripheral human B cell development

Journal of Biomedical Research

Volumn 29, Issue 4, 2015, Pages 264-284

  Bemark, Mats ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; MEMORY CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PLASMA CELL; PLASMABLAST; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 84941210933     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.29.20150035     Document Type: Review

References (190)

1. Ribatti D, Crivellato E, Vacca A. The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage[J]. Clin Exp Immunol, 2006;145(1):1-4.
2. Tarlinton D. Sheepish B cells: evidence for antigen-independent antibody diversification in humans and mice[J]. J Exp Med, 2008;205(6):1251-1254.
3. Vossenkamper A, Blair PA, Safinia N, et al. A role for gut-associated lymphoid tissue in shaping the human B cell repertoire[J]. J Exp Med, 2013;210(9):1665-1674.
4. Wesemann DR, Portuguese AJ, Meyers RM, et al. Microbial colonization influences early B-lineage development in the gut lamina propria[J]. Nature, 2013;501(7465):112-115.
5. Rosado MM, Aranburu A, Capolunghi F, et al. From the fetal liver to spleen and gut: the highway to natural antibody[J]. Mucosal Immunol, 2009;2(4):351-361.
6. Jung D, Giallourakis C, Mostoslavsky R, et al. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus[J]. Annu Rev Immunol, 2006; 24:541-570.
7. Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity[J]. Curr Opin Immunol, 2008; 20(6):632-638.
8. Allman D, Pillai S. Peripheral B cell subsets[J]. Curr Opin Immunol, 2008;20(2):149-157.
9. Tarlinton D, Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility[J]. Science, 2013;341(6151):1205-1211.
10. Srivastava B, Lindsley RC, Nikbakht N, et al. Models for peripheral B cell development and homeostasis[J]. Semin Immunol, 2005;17(3):175-182.
11. Melchers F. Anergic B cells caught in the act[J]. Immunity, 2006;25(6):864-867.
12. Casola S, Otipoby KL, Alimzhanov M, et al. B cell receptor signal strength determines B cell fate[J]. Nat Immunol, 2004;5(3):317-327.
13. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death[J]. Cell, 1997;90(6):1073-1083.
14. KrausM,AlimzhanovMB,RajewskyN, et al.Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer[J]. Cell, 2004;117(6):787-800.
15. Carsetti R, Köhler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment[J]. J Exp Med, 1995;181(6):2129-2140.
16. Jackson SM, Wilson PC, James JA, et al. Human B cell subsets[J]. AdvImmunol, 2008;98:151-224.
17. Bemark M, Holmqvist J, Abrahamsson J, et al. Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation-revelation of B cell developmental pathways and lineage phenotypes[J]. Clin Exp Immunol, 2012; 167(1):15-25.
18. Bohnhorst JØ, Bjørgan MB, Thoen JE, et al. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in theBcell subpopulations in patients with primary Sjögren's syndrome[J]. J Immunol, 2001;167(7):3610-3618.
19. Suryani S, Fulcher DA, Santner-Nanan B, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells[J]. Blood, 2010;115(3):519-529.
20. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors[J]. Science, 2003;301(5638):1374-1377.
21. Sims GP, Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells[J]. Blood 2005;105(11):4390-4398.
22. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man[J]. Immunol Rev, 2004;197:179-191.
23. Cuss AK, Avery DT, Cannons JL, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity[J]. J Immunol, 2006;176(3):1506-1516.
24. Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation[J]. Clin Immunol, 2008;127(1):14-25.
25. Bemark M, Friskopp L, Saghafian-Hedengren S, et al. A glycosylation-dependent CD45RB epitope defines previously unacknowledged CD27-IgMhigh B cell subpopulations enriched in young children and after hematopoietic stem cell transplantation[J]. Clin Immunol, 2013;149(3):421-431.
26. Agrawal S, Smith SABC, Tangye SG, et al. Transitional B cell subsets in human bone marrow[J]. Clin Exp Immunol, 2013;174(1):53-59.
27. Lee J, Kuchen S, Fischer R, et al. Identification and characterization of a human CD5+ pre-naive B cell population[J]. J Immunol, 2009;182(7):4116-4126.
28. Terrier B, Joly F, Vazquez T, et al. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity[J]. J Immunol, 2011;187(12):6550-6563.
29. Isnardi I, Ng Y-S, Menard L, et al. Complement receptor 2/ CD21-negative human naive B cells mostly contain autoreactive unresponsive clones[J]. Blood, 2010;115(24):5026-5036.
30. Andrews SF, Wilson PC. The anergic B cell[J]. Blood, 2010;115(24):4976-4978.
31. Wirths S, Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells[J]. Eur J Immunol, 2005;35(12):3433-3441.
32. Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy[J]. J Immunol, 2009;182(10):5982-5993.
33. Koethe S, Zander L, Köster S, et al. Pivotal Advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation[J]. J Leukoc Biol, 2011;90(1):5-19.
34. Loder F, Mutschler B, Ray RJ, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals[J]. J Exp Med, 1999;190(1):75-89.
35. Allman DM, Ferguson SE, Lentz VM, et al. Peripheral B cell maturation. II. Heat-stable antigen splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells[J]. J Immunol, 1993;151(9):4431-4444.
36. Wardemann H, Boehm T, Dear N, et al. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen[J]. J ExpMed, 2002;195(6):771-780.
37. Weller S, Braun MC, Tan BK, et al. Human blood IgM ''memory'' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire[J]. Blood, 2004;104(12):3647-3654.
38. Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling. Streptococcus pneumoniae infections are generated in the spleen[J]. J Exp Med, 2003;197(7):939-945.
39. Cameron PU, Jones P, Gorniak M, et al. Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort[J]. PLoS ONE, 2011;6(8):e23164.
40. Capolunghi F, Cascioli S, Giorda E, et al. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies[J]. J Immunol, 2008; 180(2):800-808.
41. Vantourout P, Hayday A. Six-of-the-best: unique contributions of cd T cells to immunology[J]. Nat Rev Immunol, 2013;13(2):88-100.
42. Singer A, Adoro S, Park J-H. Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice[J]. Nat Rev Immunol, 2008;8(10):788-801.
43. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions[J]. Nat Rev Immunol, 2013;13(2): 101-117.
44. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity[J]. Nat Immunol, 2010;11(1):7-13.
45. Coomes SM, Pelly VS, Wilson MS. Plasticity within the ab +CD4+ T-cell lineage: when, how and what for?[J] Open Biol, 2013;3(1):120157.
46. Wardemann H, Hammersen J, Nussenzweig MC. Human autoantibody silencing by immunoglobulin light chains[J]. J Exp Med, 2004;200(2):191-199.
47. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision[J]. Nat Rev Immunol, 2009;9(11):767-777.
48. Allman D, Calamito M. Instructing B cell fates on the fringe[J]. Immunity, 2009;30(2):175-177.
49. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions[J]. Nat Rev Immunol, 2010;11(1):34-46.
50. Montecino-Rodriguez E, Dorshkind K. B-1 B cell development in the fetus and adult[J]. Immunity, 2012;36(1):13-21.
51. Garraud O, Borhis G, Badr G, et al. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond[J]. BMC Immunol, 2012;13(1):63.
52. Hayakawa K, Hardy RR, Herzenberg LA, et al. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells[J]. J Exp Med, 1985;161(6):1554-1568.
53. Arnon TI, Horton RM, Grigorova IL, et al. Visualization of splenic marginal zone B-cell shuttling and follicular Bcell egress[J]. Nature, 2013;493(7434):684-688.
54. Zhang X. Regulatory functions of innate-like B cells[J]. Cell Mol Immunol, 2013;10(2):113-121.
55. Mabbott NA, Gray D. Identification of co-expressed gene signatures in mouse B1, marginal zone and B2 B-cell populations[J]. Immunology, 2014;141(1):79-95.
56. Kroese FG, Cebra JJ, van der Cammen MJ, et al. Contribution of B-1 cells to intestinal IgA production in the mouse[J]. Methods, 1995;8(1):37-43.
57. Bemark M, Boysen P, Lycke NY. Induction of gut IgA production through T cell-dependent and T cell-independent pathways[J]. Ann N Y Acad Sci, 2012;1247(1):97-116.
58. Lycke N, Bemark M. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins[J]. Mucosal Immunol, 2010;3(6):556-566.
59. Bergqvist P, Stensson A, Lycke NY, et al. T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation[J]. J Immunol, 2010;184(7):3545-3553.
60. Lindner C, Wahl B, Föhse L, et al. Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine[J]. J Exp Med, 2012;209(2):365-377.
61. Thurnheer MC, Zuercher AW, Cebra JJ, et al. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice[J]. J Immunol, 2003;170(9):4564-4571.
62. Srivastava B, Quinn WJ, Hazard K, et al. Characterization of marginal zone B cell precursors[J]. J Exp Med, 2005;202(9):1225-1234.
63. Carey JB, Moffatt-Blue CS, Watson LC, et al. Repertoirebased selection into the marginal zone compartment during B cell development[J]. J Exp Med, 2008;205(9):2043-2052.
64. Ghosn EEB, Yang Y, Tung J, et al. CD11b expression distinguishes sequential stages of peritoneal B-1 development[J]. Proc Natl Acad Sci USA, 2008;105(13): 5195-5200.
65. Klein U, Rajewsky K, Küppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells[J]. J Exp Med, 1998; 188(9):1679-1689.
66. Spencer J, Perry ME, Dunn-Walters DK. Human marginal-zone B cells[J]. Immunol Today, 1998;19(9):421-426.
67. Weill J-C, Weller S, Reynaud C-A. Human marginal zone B cells[J]. Annu Rev Immunol, 2009;27:267-285.
68. DaggMK, LevittD.Human B-lymphocyte subpopulations. I. Differentiation of density-separated B lymphocytes[J]. Clin Immunol Immunopathol, 1981;21(1):39-49.
69. Dono M, Zupo S, Leanza N, et al. Heterogeneity of tonsillarsubepithelial B lymphocytes, the splenic marginal zone equivalents[J]. J Immunol, 2000;164(11):5596-5604.
70. Fecteau JF, Côté G, Néron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation[J]. J Immunol, 2006;177(6):3728-3736.
71. Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells[J]. Eur J Immunol, 2006;36(4):810-816.
72. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells[J]. Blood, 2003;101(11):4500-4504.
73. Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells[J]. J Immunol, 2009;182(2):890-901.
74. Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes[J]. Nat Rev Immunol, 2013;13(2):118-132.
75. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells[J]. J Exp Med, 1995;182(2):559-566.
76. Tangye SG, Liu YJ, Aversa G, et al. Identification of functional human splenic memory B cells by expression of CD148 and CD27[J]. J Exp Med, 1998;188(9):1691-1703.
77. Zandvoort A, Lodewijk ME, de Boer NK, et al. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells[J]. Tissue Antigens, 2001;58(4):234-242.
78. Weller S, Mamani-Matsuda M, Picard C, et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM + IgD + CD27 + B cell repertoire in infants[J]. J Exp Med, 2008;205(6):1331-1342.
79. Amlot PL, Hayes AE. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy[J]. Implications for post-splenectomy infections. Lancet, 1985;1(8436):1008-1011.
80. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory"[J]. Immunol Rev, 2000;175: 70-79.
81. Amlot PL, Hayes AE, Gray D, et al. Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine[J]. Clin Exp Immunol, 1986;64(1):125-135.
82. Di SabatinoA,CarsettiR,Corazza GR. Post-splenectomy and hyposplenic states[J]. Lancet, 2011;378(9785):86-97.
83. Spencer J, Finn T, Pulford KA, et al. The human gut contains a novel population of B lymphocytes which resemble marginal zone cells[J]. Clin Exp Immunol, 1985;62(3):607-612.
84. Morente M, Piris MA, Orradre JL, et al. Human tonsil intraepithelial B cells: a marginal zone-related subpopulation[J]. J Clin Pathol, 1992;45(8):668-672.
85. van den Oord JJ, de Wolf-Peeters C, Desmet VJ. The marginal zone in the human reactive lymph node[J]. Am J Clin Pathol, 1986;86(4):475-479.
86. Tierens A, Delabie J, Michiels L, et al. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion[J]. Blood, 1999;93(1):226-234.
87. Dunn-Walters DK, Isaacson PG, Spencer J. Sequence analysis of rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells[J]. Immunology, 1996; 88(4):618-624.
88. Cinamon G, Zachariah MA, Lam OM, et al. Follicular shuttling of marginal zone B cells facilitates antigen transport[J]. Nat Immunol, 2008;9(1):54-62.
89. Ferguson AR, Youd ME, Corley RB. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells[J]. IntImmunol, 2004; 16(10):1411-1422.
90. Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans[J]. Proc Natl Acad Sci USA, 2001;98(3):1166-1170.
91. Agematsu K, Nagumo H, Shinozaki K, et al. Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome[J]. J Clin Invest, 1998;102(4):853-860.
92. Berkowska MA, Driessen GJA, Bikos V, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways[J]. Blood, 2011;118(8):2150-2158.
93. Wu Y-C, Kipling D, Leong HS, et al. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations[J]. Blood, 2010;116(7):1070-1078.
94. Weller S, Bonnet M, Delagreverie H, et al. IgM + IgD + CD27 + B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP-but not UNC-93B-deficient patients[J]. Blood, 2012;120(25):4992-5001.
95. Bourke E, Bosisio D, Golay J, et al. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells[J]. Blood, 2003;102(3):956-963.
96. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells[J]. Science, 2002;298(5601):2199-2202.
97. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens[J]. N Engl J Med, 2007;357(19):1903-1915.
98. RosadoMM, Gesualdo F, Marcellini V, et al. Preserved antibody levels and loss ofmemoryBcells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies[J]. Eur J Immunol, 2013;43(10):2659-2670.
99. Rosado MM, Scarsella M, Pandolfi E, et al. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example[J]. Eur J Immunol, 2011;41(6):1800-1808.
100. Kubicka U, Olszewski WL, Tarnowski W, et al. Normal human immune peritoneal cells: subpopulations and functional characteristics[J]. Scand J Immunol, 1996;44(2): 157-163.
101. Donze HH, Lue C, Julian BA, et al. Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels[J]. Clin Exp Immunol, 1997;109(2):356-561.
102. Boursier L, Montalto SA, Raju S, et al. Characterization of cells of the B lineage in the human adult greater omentum[J]. Immunology, 2006;119(1):90-97.
103. Ledbetter JA, Evans RL, Lipinski M, et al. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man[J]. J Exp Med, 1981; 153(2):310-323.
104. Bhat NM, Kantor AB, Bieber MM, et al. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells[J]. Int Immunol, 1992;4(2):243-252.
105. DonoM, Cerruti G, Zupo S. The CD5+ B-cell. Int J Biochem Cell Biol, 2004;36(11):2105-2111.
106. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-[J]. J Exp Med, 2011;208(1):67-80.
107. Griffin DO, Rothstein TL. A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus[J]. J Exp Med, 2011;208(13):2591-2598.
108. Griffin DO, Rothstein TL. Human ''orchestrator'' CD11b+ B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity[J]. Mol Med, 2012;18:1003-1008.
109. Tørring C, Petersen CC, Bjerg L, et al. The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis[J]. J Neuroimmunol, 2013;262(1-2): 92-99.
110. Kraljevic K, Wong S, Fulcher DA. Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels[J]. Clin Exp Immunol, 2013;171(3):278-282.
111. Suchanek O, Sadler R, Bateman EA, et al. Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients[J]. Clin Exp Immunol, 2012;170(3):333-341.
112. Moins-Teisserenc H, Busson M, Herda A, et al. CD19+CD5+ B cells and B1-like cells following allogeneic hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2013;19(6):988-991.
113. Verbinnen B, Covens K, Moens L, et al. Human CD20+CD43+CD27+CD5-B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae[J]. J Allergy Clin Immunol, 2012;130(1):272-275.
114. Leggat DJ, Khaskhely NM, Iyer AS, et al. Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+ +CD3-CD70-CD27 + IgM + CD43 + CD5 +/-[J]. Vaccine, 2013; 31(41):4632-4640.
115. Vuyyuru R, Liu H, Manser T, et al. Characteristics of Borreliahermsii infection in human hematopoietic stem cellengrafted mice mirror those of human relapsing fever[J]. Proc Natl Acad Sci USA, 2011;108(51):20707-20712.
116. Reynaud C-A, Weill J-C. Gene profiling of CD11b+ and CD11b-B1 cell subsets reveals potential cell sorting artifacts[J]. J Exp Med, 2012;209(3):433-434.
117. Descatoire M, Weill J-C, Reynaud C-A, et al. A human equivalent of mouse B-1 cells? J Exp Med, 2011;208(13): 2563-2564.
118. Perez-Andres M, Grosserichter-Wagener C, Teodosio C, et al. The nature of circulating CD27+CD43+ B cells. J Exp Med, 2011;208(13):2565-2566.
119. Griffin DO, Rothstein TL. Human B1 cell frequency: isolation and analysis of human B1 cells[J]. Front Immun, 2012;3:122.
120. Covens K, Verbinnen B, Geukens N, et al. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype[J]. Blood, 2013;121(26): 5176-5183.
121. Rothstein TL, Griffin DO, Holodick NE, et al. Human B-1 cells take the stage[J]. Ann N Y Acad Sci, 2013;1285:97-114.
122. Tangye SG. To B1 or not to B1: that really is still the question! Blood, 2013;121(26):5109-5110.
123. Descatoire M, Weller S, Irtan S, et al. Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties[J]. J Exp Med, 2014;211(5):987-1000.
124. Harwood NE, Batista FD. The antigen expressway: follicular conduits carry antigen to B cells[J]. Immunity, 2009;30(2):177-179.
125. Roozendaal R, Mempel TR, Pitcher LA, et al. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles[J]. Immunity, 2009;30(2):264-276.
126. Garside P, Ingulli E, Merica RR, et al. Visualization of specific B and T lymphocyte interactions in the lymph node[J]. Science, 1998;281(5373):96-99.
127. Goodnow CC, Vinuesa CG, Randall KL, et al. Control systems and decision making for antibody production[J]. Nat Immunol, 2010;11(8):681-688.
128. MacLennan ICM, Toellner K-M, Cunningham AF, et al. Extrafollicular antibody responses[J]. Immunol Rev, 2003;194:8-18.
129. Victora GD, Nussenzweig MC. Germinal centers[J]. Annu Rev Immunol, 2012;30:429-457.
130. Pascual V, Liu YJ, Magalski A, et al. Analysis of somatic mutation in five B cell subsets of human tonsil[J]. J Exp Med, 1994;180(1):329-339.
131. Liu YJ, Barthélémy C, De Bouteiller O, et al. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2[J]. Immunity, 1995;2(3):239-248.
132. Victora GD, Schwickert TA, Fooksman DR, et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter[J]. Cell, 2010;143(4):592-605.
133. Victora GD, Dominguez-Sola D, Holmes AB, et al. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas[J]. Blood, 2012;120(11):2240-2248.
134. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes[J]. Immunology, 1970;18(5):723-737.
135. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995;155(3):1151-1164.
136. Wolf SD, Dittel BN, Hardardottir F, et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice[J]. J Exp Med, 1996;184(6):2271-2278.
137. Mauri C, Gray D, Mushtaq N, et al. Prevention of arthritis by interleukin 10-producing B cells[J]. J Exp Med, 2003;197(4):489-501.
138. Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10[J]. Nat Immunol, 2002;3(10):944-950.
139. Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation[J]. Immunity, 2002;16(2):219-230.
140. Mauri C, Bosma A. Immune regulatory function of B cells[J]. Annu Rev Immunol, 2012;30:221-241.
141. Gray D, Gray M. What are regulatory B cells? Eur J Immunol, 2010;40(10):2677-2679.
142. Ries S, Hilgenberg E, Lampropoulou V, et al. B-type suppression: A role played by "regulatory B cells" or "regulatory plasma cells"?[J] Eur J Immunol, 2014;44(5): 1251-1257.
143. Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases[J]. Nature, 2014; 507(7492):366-370.
144. Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis[J]. J Immunol, 2007;178(10):6092-6099.
145. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis[J]. Ann Neurol, 2007;61(2):97-108.
146. Correale J, Farez M, Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells[J]. Ann Neurol, 2008;64(2):187-199.
147. Blair PA, Noreña LY, Flores-Borja F, et al. CD19+ CD24hiCD38hi B Cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients[J]. Immunity, 2010;32(1):129-140.
148. Lemoine S, Morva A, Youinou P, et al. Human T cells induce their own regulation through activation of B cells[J]. J Autoimmun, 2011;36(3-4):228-238.
149. Flores-Borja F, BosmaA,NgD, et al. CD19+CD24hiCD38hi B cellsmaintain regulatoryTcellswhile limitingTH1 andTH17 differentiation[J]. Sci Transl Med, 2013;5(173):173ra23.
150. Li X, Zhong H, Bao W, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia[J]. Blood, 2012;120(16):3318-3325.
151. Hua F, Ji L, Zhan Y, et al. Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia[J]. J Clin Immunol, 2012;32(6):1233-1242.
152. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans[J]. J Clin Invest, 2010;120(6):1836-1847.
153. Das A, Ellis G, Pallant C, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection[J]. J Immunol, 2012;189(8):3925-3935.
154. Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro[J]. J Leukoc Biol, 2013;93(5):811-818.
155. Bouaziz J-D, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro[J]. Eur J Immunol, 2010;40(10):2686-2691.
156. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells[J]. Blood, 2011;117(2):530-541.
157. ZhaB,Wang L, LiuX, et al.Decrease in proportion of CD19+ CD24hi CD27+ B cells and impairment of their suppressive function in Graves' disease[J]. PLoS ONE, 2012;7(11): e49835.
158. van Zelm MC, Bartol SJW, Driessen GJ, et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation[J]. J Allergy Clin Immunol, 2014;134(1):135-144.
159. Bergqvist P, Gärdby E, Stensson A, et al. Gut IgA class switch recombination in the absence of CD40 does not occur in the lamina propria and is independent of germinal centers[J]. J Immunol, 2006;177(11):7772-7783.
160. He B, Xu W, Santini PA, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL[J]. Immunity, 2007;26(6):812-826.
161. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface[J]. Annu Rev Immunol, 2011; 29:273-293.
162. Lin M, Du L, Brandtzaeg P, et al. IgA subclass switch recombination in human mucosal and systemic immune compartments[J]. Mucosal Immunol, 2014;7(3):511-520.
163. Barone F, Patel P, Sanderson JD, et al. Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination[J]. Mucosal Immunol, 2009;2(6):495-503.
164. Shikina T, Hiroi T, Iwatani K, et al. IgA class switch occurs in the organized nasopharynx-and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut[J]. J Immunol, 2004;172(10):6259-6264.
165. Barone F, Vossenkamper A, Boursier L, et al. IgA-producing plasma cells originate from germinal centers that are induced by B-cell receptor engagement in humans[J]. Gastroenterology, 2011;140(3):947-956.
166. Amanna IJ, Slifka MK. Quantitation of rare memory B cell populations by two independent and complementary approaches[J]. J ImmunolMethods, 2006;317(1-2):175-185.
167. Pinna D, Corti D, Jarrossay D, et al. Clonal dissection of the human memory B-cell repertoire following infection and vaccination[J]. Eur J Immunol, 2009;39(5):1260-1270.
168. van Es JH, Meyling FH, Logtenberg T. High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire[J]. Eur J Immunol, 1992;22(10): 2761-2764.
169. Huang C, Stewart AK, Schwartz RS, et al. Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes[J]. J Clin Invest, 1992;89(4):1331-1343.
170. Klein U, Küppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans[J]. Blood, 1997;89(4):1288-1298.
171. Dogan I, Bertocci B, Vilmont V, et al. Multiple layers of B cell memory with different effector functions[J]. Nat Immunol, 2009;10(12):1292-1299.
172. Pape KA, Taylor JJ, Maul RW, et al. Different B cell populations mediate early and late memory during an endogenous immune response[J]. Science, 2011;331(6021): 1203-1207.
173. Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or ''memory'' B cells?[J] J Immunol, 2007;179(1): 13-19.
174. Seifert M, Küppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation[J]. J Exp Med, 2009;206(12):2659-2669.
175. Vinuesa CG, Chang P-P. Innate B cell helpers reveal novel types of antibody responses[J]. Nat Immunol, 2013;14(2): 119-126.
176. Bortnick A, Allman D. What is and what should always have been: long-lived plasma cells induced by T cellindependent antigens[J]. J Immunol, 2013;190(12): 5913-5918.
177. Chu VT, Berek C. The establishment of the plasma cell survival niche in the bone marrow[J]. Immunol Rev, 2013;251(1):177-188.
178. Chevrier S, Emslie D, Shi W, et al. The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity[J]. J Exp Med, 2014; 211(5):827-840.
179. Wang Y, Bhattacharya D. Adjuvant-specific regulation of long-term antibody responses by ZBTB20[J]. J Exp Med, 2014;211(5):841-856.
180. Amanna IJ, Slifka MK. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity[J]. Immunol Rev, 2010;236:125-138.
181. Di Niro R, Mesin L, Raki M, et al. Rapid generation of rotavirus-specific human monoclonal antibodies from smallintestinal mucosa[J]. J Immunol, 2010;185(9):5377-5383.
182. Pinto D, Montani E, Bolli M, et al. A functional BCR in human IgA and IgM plasma cells[J]. Blood, 2013;121(20): 4110-4114.
183. Czerkinsky CC, Tarkowski A, Nilsson LA, et al. Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances[J]. J Immunol Methods, 1984;72(2):489-496.
184. Wrammert J, Smith K, Miller J, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus[J]. Nature, 2008;453(7195):667-671.
185. Wrammert J, Koutsonanos D, Li G-M, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection[J]. J Exp Med, 2011;208(1):181-193.
186. Wrammert J, Onlamoon N, Akondy RS, et al. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans[J]. J Virol, 2012; 86(6):2911-2918.
187. Mei HE, Yoshida T, Sime W, et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses[J]. Blood, 2009; 113(11): 2461-2469.
188. Mei HE, Frölich D, Giesecke C, et al. Steady-state generation of mucosal IgA+plasmablasts is not abrogated by B-cell depletion therapy with rituximab[J]. Blood, 2010;116(24): 5181-5190.
189. Rahman A, Rashu R, Bhuiyan TR, et al. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh[J]. Clin Vaccine Immunol, 2013;20(10):1592-1598.
190. Czerkinsky C, Svennerholm AM, Quiding M, et al. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans[J]. Infect Immun, 1991;59(3):996-1001.